Galidesivir
Broad‑spectrum antiviral for RNA viruses (e.g., Ebola, Zika, Marburg)
Clinical stage (potential acquisition)Exploratory
Key Facts
Indication
Broad‑spectrum antiviral for RNA viruses (e.g., Ebola, Zika, Marburg)
Phase
Clinical stage (potential acquisition)
Status
Exploratory
Company
About Island Pharmaceuticals
Australian biotech repurposing antivirals for dengue and other vector‑borne diseases, with a Phase 2a/b trial of ISLA‑101.
View full company profile